Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates

Summary by Joplin Globe
WALTHAM, Mass.--(BUSINESS WIRE)--Sep 15, 2025-

3 Articles

Joplin GlobeJoplin Globe
Reposted by
The AI JournalThe AI Journal
Center

Viridian Therapeutics Announces Completion of Enrollment in both REVEAL Clinical Trials and Positive Portfolio Updates

WALTHAM, Mass.--(BUSINESS WIRE)--Sep 15, 2025-

Read Full Article
ophthalmologytimes.comophthalmologytimes.com

Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003

Viridian plans to submit a Biologics License Application (BLA) for VRDN-003 by year-end of 2026.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Joplin Globe broke the news in on Monday, September 15, 2025.
Sources are mostly out of (0)

Similar News Topics

Waltham, Massachusetts icon

Waltham, Massachusetts

News
For You
SearchBlindspotLocal